Toggle sidebar
定价
登录
Treatment for thyroid eye disease
搜索文档
Viridian Therapeutics Stock Is Tanking. Why the Drop Is Linked to This Amgen Study.
Barrons
·
2026-04-07 00:10
公司动态 - 安进公司宣布其针对甲状腺眼病的新疗法在3期临床试验中取得积极结果 [1] - Viridian Therapeutics公司目前也在开发针对该疾病的自身疗法 [1]
安进(US:AMGN)
Biotechnology
Treatment for thyroid eye disease
Biotechnology
Treatment for thyroid eye disease